IL10 and colorectal carcinoma: Additionally, CRC can inhibit CTL cytotoxic activity by expressing immune checkpoint molecules and secreting immunosuppressive cytokines, including interleukin-10 (IL-10) and transforming growth factor-β (TGF-β) (27).